Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5077
Source ID: NCT00624364
Associated Drug: Biphasic Insulin Aspart
Title: Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: biphasic insulin aspart|DRUG: metformin
Outcome Measures: Primary: HbA1c, after 24 weeks of treatment | Secondary: Plasma glucose profiles|Cardiovascular risk factors|Incidence of hypoglycaemic episodes|Adverse events
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 140
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2004-05
Completion Date: 2005-05
Results First Posted:
Last Update Posted: 2017-01-06
Locations: Novo Nordisk Investigational Site, Bloemfontein, Free State, 9301, South Africa|Novo Nordisk Investigational Site, Johannesburg, Gauteng, 1827, South Africa|Novo Nordisk Investigational Site, Johannesburg, Gauteng, 1829, South Africa|Novo Nordisk Investigational Site, Johannesburg, Gauteng, 2001, South Africa|Novo Nordisk Investigational Site, Pretoria, Gauteng, 0116, South Africa|Novo Nordisk Investigational Site, Durban, KwaZulu-Natal, 4001, South Africa|Novo Nordisk Investigational Site, Durban, KwaZulu-Natal, 4091, South Africa|Novo Nordisk Investigational Site, Pietermaritzburg, KwaZulu-Natal, 3235, South Africa|Novo Nordisk Investigational Site, Brits, North West, 0250, South Africa|Novo Nordisk Investigational Site, Cape Town, Western Cape, 7708, South Africa|Novo Nordisk Investigational Site, Cape Town, Western Cape, 7800, South Africa|Novo Nordisk Investigational Site, Benoni, 1500, South Africa|Novo Nordisk Investigational Site, Bloemfontein, 27 51, South Africa|Novo Nordisk Investigational Site, Kimberley, 8301, South Africa|Novo Nordisk Investigational Site, Richards Bay, 3900, South Africa
URL: https://clinicaltrials.gov/show/NCT00624364

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D089 Metformin small molecule DB00331 Details